• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥大细胞、血管生成与非小细胞肺癌预后之间缺乏相关性。

A lack of correlation between mast cells, angiogenesis, and outcome in non-small cell lung cancer.

作者信息

Niczyporuk Marek, Hermanowicz Adam, Matuszczak Ewa, Dziadziuszko Rafał, Knaś Małgorzata, Zalewska Anna, Chyczewski Lech

机构信息

Laboratory of Esthetic Medicine, Medical University of Bialystok, Bialystok, Poland.

出版信息

Exp Lung Res. 2012 Aug;38(6):281-5. doi: 10.3109/01902148.2012.686559. Epub 2012 May 30.

DOI:10.3109/01902148.2012.686559
PMID:22646306
Abstract

Although a direct association between mast cells and cancer tumors is generally accepted, the exact nature of this relationship appears contradictory. The aim of this study was to clarify the effect of mast cells on tumor angiogenesis and outcome in Non-small cell lung cancer (NSCLC) patients. The tissue specimens evaluated were from patients with NSCLC who had undergone resection with curative intent at the Medical University of Bialystok Hospital. Of the 90 patients studied, 67 were men. Average age at surgery was 59.68 years. Study population included 29 cases of adenocarcinoma, 44 cases of squamous cell carcinoma, and 17 cases of large cell carcinoma. The authors counted mast cells and microvessels in tumor sections. Mast cells were observed in small groups around vessels and in the cancer parenchyma. At a magnification of 200×, the number of mast cells was 28.90 ± 16.6. Intramural microvessels in endothelial cells were found in small groups, mostly at the margin. At a magnification of 200×, the number of microvessels was 221.69 ± 120.36. Spearman correlation was observed in patients with adenocarcinoma, and also in patients with stage II disease. This study did not show correlation between mast cells count and survival rate, and correlation between microvessel count and survival rate. In this study, mast cells infiltration of the tumor islets was not associated with patients' survival. The authors did not find correlation between mast cells count and angiogenesis, except only in patients with adenocarcinoma, and in patients with stage II disease.

摘要

尽管肥大细胞与癌症肿瘤之间的直接关联已被普遍接受,但这种关系的确切性质似乎相互矛盾。本研究的目的是阐明肥大细胞对非小细胞肺癌(NSCLC)患者肿瘤血管生成及预后的影响。所评估的组织标本来自在比亚韦斯托克医科大学医院接受根治性切除的NSCLC患者。在研究的90例患者中,67例为男性。手术时的平均年龄为59.68岁。研究人群包括29例腺癌、44例鳞状细胞癌和17例大细胞癌。作者对肿瘤切片中的肥大细胞和微血管进行了计数。肥大细胞在血管周围小群出现,并存在于癌实质中。在200倍放大倍数下,肥大细胞数量为28.90±16.6。内皮细胞内的壁内微血管小群出现,大多位于边缘。在200倍放大倍数下,微血管数量为221.69±120.36。在腺癌患者以及II期疾病患者中观察到斯皮尔曼相关性。本研究未显示肥大细胞计数与生存率之间的相关性,以及微血管计数与生存率之间的相关性。在本研究中,肿瘤小岛的肥大细胞浸润与患者生存率无关。作者未发现肥大细胞计数与血管生成之间的相关性,仅在腺癌患者以及II期疾病患者中除外。

相似文献

1
A lack of correlation between mast cells, angiogenesis, and outcome in non-small cell lung cancer.肥大细胞、血管生成与非小细胞肺癌预后之间缺乏相关性。
Exp Lung Res. 2012 Aug;38(6):281-5. doi: 10.3109/01902148.2012.686559. Epub 2012 May 30.
2
Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance.非小细胞肺癌中的肥大细胞表型和微血管及其预后意义。
Hum Pathol. 2010 May;41(5):697-705. doi: 10.1016/j.humpath.2009.04.029. Epub 2009 Dec 29.
3
The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.I期非小细胞肺癌中类胰蛋白酶和糜酶阳性肥大细胞与血管生成的关系。
Eur J Cardiothorac Surg. 2005 Oct;28(4):617-21. doi: 10.1016/j.ejcts.2005.06.020.
4
Effect of mast cells on tumor angiogenesis in lung cancer.肥大细胞对肺癌肿瘤血管生成的影响。
Ann Thorac Surg. 2000 Jun;69(6):1686-90. doi: 10.1016/s0003-4975(00)01160-7.
5
Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.抗VIII因子和抗CD31免疫染色评估非小细胞肺癌血管生成的比较性评价
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2485-92.
6
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.微血管计数可预测非小细胞肺癌的转移情况及生存率。
J Pathol. 1995 Sep;177(1):57-63. doi: 10.1002/path.1711770110.
7
[Relation of tumor associated macrophages and mast cells of tumor interstitial and angiogenesis in non-small cell lung cancer].[非小细胞肺癌中肿瘤间质的肿瘤相关巨噬细胞和肥大细胞与血管生成的关系]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Dec;32(6):1037-41.
8
Patterns of angiogenesis in nonsmall-cell lung carcinoma.非小细胞肺癌中的血管生成模式
Cancer. 2001 Apr 15;91(8):1500-9.
9
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.血管内皮生长因子、血小板衍生内皮细胞生长因子与非小细胞肺癌中的血管生成
Br J Cancer. 2000 Apr;82(8):1427-32. doi: 10.1054/bjoc.1999.1129.
10
Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.癌巢中巨噬细胞和CD8(+) T细胞的主要浸润是IV期非小细胞肺癌患者生存的重要预测指标。
Cancer. 2008 Sep 15;113(6):1387-95. doi: 10.1002/cncr.23712.

引用本文的文献

1
Identification and verification of immune and oxidative stress-related diagnostic indicators for malignant lung nodules through WGCNA and machine learning.通过加权基因共表达网络分析(WGCNA)和机器学习识别并验证恶性肺结节的免疫和氧化应激相关诊断指标
Sci Rep. 2025 Jul 1;15(1):22449. doi: 10.1038/s41598-025-04639-4.
2
Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis.肺腺癌中肥大细胞浸润的特征及其对预后的影响。
Discov Oncol. 2024 Jun 4;15(1):208. doi: 10.1007/s12672-024-01062-5.
3
Controversial role of mast cells in NSCLC tumor progression and angiogenesis.
肥大细胞在非小细胞肺癌肿瘤进展和血管生成中的争议性作用。
Thorac Cancer. 2022 Nov;13(21):2929-2934. doi: 10.1111/1759-7714.14654. Epub 2022 Oct 4.
4
Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.宿主相关因素可作为非小细胞肺癌患者免疫治疗反应的靶点驱动因素。
Front Immunol. 2022 Jul 6;13:914890. doi: 10.3389/fimmu.2022.914890. eCollection 2022.
5
Evaluation of mast cell counts and microvessel density in reactive lesions of the oral cavity.口腔反应性病变中肥大细胞计数及微血管密度的评估
J Dent Res Dent Clin Dent Prospects. 2016 Fall;10(4):241-246. doi: 10.15171/joddd.2016.038. Epub 2016 Dec 21.
6
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.个体化的免疫系统调节可能会彻底改变未来的肺癌治疗方式。
BMC Cancer. 2012 Dec 5;12:580. doi: 10.1186/1471-2407-12-580.